Suppr超能文献

发现一种在 MC1R、MC3R、MC4R 和 MC5R 上具有作用的黑色素浓缩激素受体拮抗剂 [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH],它介导了小鼠摄食反应增加,同时也是一种具有 40 倍选择性的 MC1R 拮抗剂 [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH]。

Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH].

机构信息

Department of Medicinal Chemistry and Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.

出版信息

J Med Chem. 2023 Jun 22;66(12):8103-8117. doi: 10.1021/acs.jmedchem.3c00432. Epub 2023 Jun 12.

Abstract

Discovery of pan-antagonist ligands for the melanocortin receptors will help identify the physiological activities controlled by these receptors. The previously reported MC3R/MC4R antagonist Ac-DPhe(pI)-Arg-Nal(2')-Arg-NH was identified herein, for the first time, to possess MC1R and MC5R antagonist activity. Further structure-activity relationship studies probing the second and fourth positions were performed toward the goal of identifying potent melanocortin antagonists. Of the 21 tetrapeptides synthesized, 13 possessed MC1R, MC3R, MC4R, and MC5R antagonist activity. Three tetrapeptides were more than 10-fold selective for the mMC1R, including (LTT1-44, Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH) that possessed 80 nM mMC1R antagonist potency and was at least 40-fold selective over the mMC3R, mMC4R, and mMC5R. Nine tetrapeptides were selective for the mMC4R, including [SSM1-8, Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH] with an mMC4R antagonist potency of 1.6 nM. This compound was administered IT into mice, resulting in a dose-dependent increase in the food intake and demonstrating the in vivo utility of this compound series.

摘要

发现黑色素浓缩素受体的泛拮抗剂配体将有助于确定这些受体控制的生理活性。本文首次报道了先前报道的 MC3R/MC4R 拮抗剂 Ac-DPhe(pI)-Arg-Nal(2')-Arg-NH 具有 MC1R 和 MC5R 拮抗剂活性。为了鉴定有效的黑色素浓缩素拮抗剂,进一步对第二和第四位进行了结构活性关系研究。在所合成的 21 个四肽中,有 13 个具有 MC1R、MC3R、MC4R 和 MC5R 拮抗剂活性。三种四肽对 mMC1R 的选择性超过 10 倍,包括 (LTT1-44,Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH),其对 mMC1R 的拮抗效力为 80 nM,对 mMC3R、mMC4R 和 mMC5R 的选择性至少为 40 倍。有 9 个四肽对 mMC4R 具有选择性,包括 [SSM1-8,Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH],其对 mMC4R 的拮抗效力为 1.6 nM。该化合物通过 IT 给药进入小鼠,导致食物摄入量呈剂量依赖性增加,证明了该化合物系列的体内实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b5b/10631449/1adab22d5eda/nihms-1939606-f0002.jpg

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验